Gingko Biloba

DRUG6 trials

Sponsors

National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health Clinical Center (CC), King Saud University, Bagcilar Training and Research Hospital, Boehringer Ingelheim

Conditions

AsthmaGlaucomaHealthyVitiligo

Phase 1

Borage Oil and Ginkgo Biloba (EGb 761) in Asthma

CompletedNCT00029679

National Center for Complementary and Integrative Health (NCCIH)Asthma

Start: 2000-09-30End: 2005-07-31Target: 280Updated: 2006-08-18

Phase 3

Impact of Oral Versatile Antioxidants on Glaucoma Progression

CompletedNCT01544192

Bagcilar Training and Research HospitalGlaucoma

Start: 2008-04-30End: 2012-02-29Updated: 2012-03-05

Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults

CompletedNCT02181972

Boehringer IngelheimHealthy

Start: 2002-05-31Updated: 2014-07-18

Phase 4

Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers

CompletedNCT00103012

National Institutes of Health Clinical Center (CC)Healthy

Start: 2005-01-31End: 2011-06-30Updated: 2012-04-16

Unknown Phase

Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo

King Saud UniversityVitiligo

Start: 2009-01-31End: 2011-01-31Target: 160Updated: 2009-11-05

Effects of Ginkgo (Gingko Biloba) on Retinal and Choroidal Ocular Tissue

CompletedNCT04448535

State University of New York College of OptometryHealthy

Start: 2021-01-01End: 2022-08-03Updated: 2022-10-24